iohexol

Uses your system voice; voice and rate in settings.

Q410683Snapshot

≈ 3 min read

Names in other languages

  • shJoheksol
  • СрпскиJoheksol
  • DeutschIohexol
  • Englishiohexol
  • Françaisiohexol
  • Italianoioexolo
  • 日本語イオヘキソール
  • Nederlandsiohexol

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Iohexol, sold under the trade names Omnipaque and Iodaque among others, is a contrast agent used for X-ray imaging. This includes when visualizing arteries, veins, ventricles of the brain, the urinary system, and joints, as well as during computed tomography (CT scan). It is given by mouth, injection into a vein, or into a body cavity. Side effects include vomiting, skin flushing, headache, itchiness, kidney problems, and low blood pressure. Less commonly allergic reactions or seizures may occur. Allergies to povidone-iodine or shellfish do not affect the risk of side effects more than other allergies. Use in the later part of pregnancy may cause hypothyroidism in the baby. Iohexol is an iodinated non-ionic radiocontrast agent. It is in the low osmolar family. Iohexol was approved for medical use in 1985. It is on the World Health Organization's List of Essential Medicines.

Iohexol, sold under the trade names Omnipaque and Iodaque among others, is a contrast agent used for X-ray imaging. This includes when visualizing arteries, veins, ventricles of the brain, the urinary system, and joints, as well as during computed tomography (CT scan). It is given by mouth, injection into a vein, or into a body cavity. Side effects include vomiting, skin flushing, headache, itchiness, kidney problems, and low blood pressure. Less commonly allergic reactions or seizures may occur. Allergies to povidone-iodine or shellfish do not affect the risk of side effects more than other allergies. Use in the later part of pregnancy may cause hypothyroidism in the baby. Iohexol is an iodinated non-ionic radiocontrast agent. It is in the low osmolar family. Iohexol was approved for medical use in 1985. It is on the World Health Organization's List of Essential Medicines.

Chemistry

The osmolality of iohexol ranges from 322 mOsm/kg—approximately 1.1 times that of blood plasma—to 844 mOsm/kg, almost three times that of blood. Despite this difference, iohexol is still considered a low-osmolality contrast agent; the osmolality of older agents, such as diatrizoate, may be more than twice as high.

Adverse effects

The most common side effects after intravenous injections are: pain at the site of injection (3%), blurring of vision (2%), nausea (2%), arrhythmia (2%), taste perversion (1%), hypotension (0.7%), and vomiting (0.7%).

Society and culture

Naming

It is sold under the brand name Omnipaque. It is also sold as a density gradient medium under the names Accudenz, Histodenz, and Nycodenz.

Available forms

It is available in various concentrations, from 140 to 350 milligrams of iodine per milliliter. Iohexol can be given as intrathecal, intravascular, oral, rectal, intraarticular, or into the body cavity.

References

Text derived from https://en.wikipedia.org/w/index.php?oldid=1368028914 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.